DPP4 and chronic kidney disease: Moreover, our data show that the cardioprotection conferred by DPPIV inhibition in CKD rats is associated with a reduction in the cardiac levels of Ang II and an augmentation in the levels of angiotensin-(1-7), which were accompanied by pronounced local anti-hypertrophic, anti-inflammatory and antioxidant effects.